世界のデジタル治療の市場規模は2030年までに325億ドルに達すると予想されます。この市場は2022年から2030年までに26.1％のCAGRで大きく成長すると予想されます。市場の成長を促進する主な要因としては、COVID-19のパンデミックによる高い需要、さまざまな支援的規制政策と保険適用の初期兆候、先進国と発展途上国でのスマートフォンの普及率の増加、慢性疾患の蔓延などが挙げられます。さらに、プロバイダーと患者のためのデジタルヘルステクノロジーの費用対効果、統合医療システムと患者中心のケアに対する需要の増加などが市場の成長を後押しすると予想されます。
COVID-19のパンデミックがデジタル治療ソリューションの採用を促進しました。Teladocは、遠隔医療の利用がパンデミック前から約38倍に増加したことを報告しました。さらにFDAなどの主要な規制機関による支援策がこれらのソリューションの採用を後押ししました。たとえば2020年4月、米国FDAは精神疾患患者向けのデジタルヘルス治療装置の利用可能性を拡大するためにガイドラインを策定しました。Kepiosによると、世界的に、インターネットユーザーの数は年率7.6％で増加しています。つまり、毎日平均90万人の新規ユーザーが増えています。先進国と特定の発展途上国はスマートフォンとインターネットの普及率が高い一方で、アフリカや南アジアなどの地域の国々は、経済が遅れているために低迷しています。
目次
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Demand Sizing: Disease Prevalence Based Model
1.6.3 Region Based Segment Share Calculation
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Digital Therapeutics Market Outlook, 2017 - 2030 (USD Million)
2.2 Digital Therapeutics Market Summary, 2021
Chapter 3 Digital Therapeutics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Digital Therapeutics Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 COVID-19 pandemic
3.3.1.2 Supportive regulatory initiatives & early signs of reimbursement
3.3.1.3 Increasing prevalence of chronic diseases
3.3.1.4 increasing smartphone penetration in developed and developing countries
3.3.1.5 cost-effectiveness of digital health technology for providers and patients
3.3.1.6 increasing demand for integrated healthcare systems and patient-centric care
3.3.2 Market restraint analysis
3.3.2.1 low smartphone penetration in underdeveloped countries
3.3.2.2 COncerns over data protection
3.4 Digital Therapeutics Market Analysis Tools: Porter’s Five Forces Analysis
3.4.1 Supplier Power: Low
3.4.2 Buyer Power: high
3.4.3 Threat Of Substitutes: Low
3.4.4 Threat Of New Entrants: High
3.4.5 Competitive Rivalry: High
3.5 Pestel Analysis
3.5.1 Political & Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social & Technological Landscape
3.6 Opportunity Analysis
Chapter 4 Digital Therapeutics Market: Competitive Analysis
4.1 Market Participation Categorization
4.1.1 Market Leaders & Innovators
4.1.1.1 company market position analysis
4.2 Major Deals & Strategic Alliances Analysis
4.2.1 List Of Private Companies
Chapter 5 Digital Therapeutics Market: Covid-19 Impact
5.1 Disease Prevalence Analysis
5.2 Current And Future Impact Analysis
5.2.1 Current Impact Analysis
5.2.2 Future Impact Analysis
5.3 Impact On Market Players
Chapter 6 Digital Therapeutics Market: Application Estimates & Trend Analysis
6.1 Application Market Share Analysis, 2021 & 2030
6.2 Application Dashboard
6.3 Diabetes
6.3.1 diabetes market estimates and forecasts, 2017 - 2030 (USD Million)
6.4 OBESITY
6.4.1 obesity market estimates and forecasts, 2017 - 2030 (USD Million)
6.5 CVD
6.5.1 CVD market estimates and forecasts, 2017 - 2030 (USD Million)
6.6 Respiratory Diseases
6.6.1 Respiratory diseases market estimates and forecasts, 2017 - 2030 (USD Million)
6.7 Smoking Cessation
6.7.1 Smoking cessation market estimates and forecasts, 2017 - 2030 (USD Million)
6.8 CNS DISEASES
6.8.1 CNS Diseases market estimates and forecasts, 2017 - 2030 (USD Million)
6.9 OTHERS
6.9.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 7 Digital Therapeutics Market: End-Use Estimates & Trend Analysis
7.1 End-Use Market Share Analysis, 2021 & 2030
7.2 End-Use Dashboard
7.3 Patients
7.3.1 Patients Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4 Providers
7.4.1 Providers market estimates and forecasts, 2017 - 2030 (USD Million)
7.5 Payers
7.5.1 payers market estimates and forecasts, 2017 - 2030 (USD Million)
7.6 Employers
7.6.1 employers market estimates and forecasts, 2017 - 2030 (USD Million)
7.7 Other End Users
7.7.1 Other End Users market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 8 Digital Therapeutics Market: Regional Estimates & Trend Analysis, by Application, End-Use
8.1 Regional Market Snapshot
8.2 North America
8.2.1 North America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Digital Therapeutics Market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Digital Therapeutics market estimates and forecasts, 2017 - 2030(USD Million)
8.3.3 Germany
8.3.3.1 Germany Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.2 Mexico
8.5.2.1 Mexico Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.3 Brazil
8.5.3.1 Brazil Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6 Middle East And Africa (MEA)
8.6.1 Middle East and Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
9.1 OMADA HEALTH, INC.
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 WELLDOC, INC.
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 2Morrow, Inc
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 STRATEGIC INITIATIVES
9.4 LIVONGO HEALTH, INC. (TELADOC HEALTH, INC.)
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 PROPELLER HEALTH
9.5.1 Company Overview
9.5.2 Financial PERFORMANCE
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Fitbit, Inc.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 STRATEGIC INITIATIVES
9.7 CANARY HEALTH
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 MANGO HEALTH
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 STRATEGIC INITIATIVES
9.9 NOOM, INC.
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 STRATEGIC INITIATIVES
9.10 PEAR THERAPEUTICS
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 STRATEGIC INITIATIVES
